Observational study on patients with obstructive sleep apnea in Hong Kong
Prospective Study on Patients With Obstructive Sleep Apnea in Hong Kong (PrOSA)
This study looks at how obstructive sleep apnea affects heart health and thinking skills in people from Hong Kong over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Please Select) |
| Trial ID | NCT04659291 on ClinicalTrials.gov |
What this trial studies
This study aims to observe patients with obstructive sleep apnea syndrome (OSAS) in Hong Kong to assess its impact on cardiovascular risk and cognitive function. It will involve a prospective observational approach, tracking the health outcomes of participants over time. The study seeks to fill the gap in long-term follow-up data regarding the incidence of cardiovascular disease and quality of life in OSAS patients. Participants will be monitored for their compliance with therapy and overall health status.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and above who are suspected of having obstructive sleep apnea and can communicate in Chinese or English.
Not a fit: Patients who have already received treatment for sleep apnea or have serious unrelated health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term health risks associated with obstructive sleep apnea, potentially leading to improved management strategies for patients.
How similar studies have performed: Other studies have indicated the importance of understanding the long-term effects of obstructive sleep apnea, suggesting that this approach could yield significant findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * suspected obstructive sleep apnea syndrome * aged 18 or above * must be able to speak, read and understand Chinese or English * possess the ability to respond to questions and follow instructions. Exclusion Criteria: * already treated sleep apnea, * a limited life expectancy due to illness unrelated to sleep apnea * human immunodeficiency virus (HIV), * advanced renal disease, * uncontrolled malignancies * documented alcohol or drug abuse up to 1 year prior to inclusion in the study.
Where this trial is running
Hong Kong, Please Select
- Chinese University of Hong — Hong Kong, Please Select, Hong Kong (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.